← Leaderboards
Alessandra Biffi
Dana-Farber Cancer Inst
$1,098,714
Attributed
$1,098,714
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $366.2K · FY2018–20$500K$375K$250K$125K$0
'18
'19
'20
Funding mix
By agency
NIH$1,098,714 · 1
By mechanism
R01$1,098,714 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Kenneth C Anderson$25,995,373
- Pietro Genovese$5,128,749
- Alex Kentsis$10,070,317
- Katja Gabriele Weinacht$3,414,687
- Patrick Seale$18,417,312
Others in their field
Other Emerging Leaders on “Animal Disease Models”
- Ted Ross · University Of Georgia$71,962,304
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
- Gary Fanger · Rise Therapeutics, Llc$17,167,043
- Sonia Minikel Vallabh · Broad Institute, Inc.$14,507,691
- Wilton B Williams · Duke University$13,014,035
- Richard Scranton · Lyndra Therapeutics, Inc.$12,106,230
Research focus
Animal Disease ModelsCurative TreatmentsAnimalsApplications GrantsAffectConditioningBrainBrain DiseasesCellsCell SurvivalBaseAnimal ModelBiodistributionCellular TransductionCessation Of LifeChildChildhoodClinical TranslationCln1 GeneCodeCohortComplementary DnaComplexCytoprotection
Grant awards (3)
Hematopoietic stem cell gene therapy for infantile neuronal ceroid lipofuscinosis$366,238
R01 · FY2020 · HD · contact PI
Hematopoietic stem cell gene therapy for infantile neuronal ceroid lipofuscinosis$366,238
R01 · FY2019 · HD · contact PI
Hematopoietic stem cell gene therapy for infantile neuronal ceroid lipofuscinosis$366,238
R01 · FY2018 · HD · contact PI